Adjuvance logo
Healthcare & Life Sciences

Adjuvance

Adjuvance is a Healthcare & Life Sciences startup based in France, most recent round Series A, 1 tracked investor.

series-a
series-a
Stage
1
Investors

About Adjuvance

Adjuvance is a startup based in France. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Adjuvance develops a semi-synthetic process to mass-produce a superior version of the QS21 vaccine adjuvant to improve vaccine efficacy where current adjuvants are limited by natural supply constraints.

Explore Adjuvance's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in France